3.8 Article

Co-Occurring Depressive and Substance Use Disorders in Adolescents: An Examination of Reward Responsiveness During Treatment

期刊

JOURNAL OF PSYCHOTHERAPY INTEGRATION
卷 24, 期 2, 页码 109-121

出版社

AMER PSYCHOLOGICAL ASSOC
DOI: 10.1037/a0036975

关键词

reward responsiveness; adolescent; substance abuse; depressive disorders

资金

  1. ANT North America Inc. (Advanced Neuro Technology)
  2. Astra-Zeneca
  3. Shire
  4. Servier
  5. Ono Pharma U.S.A.
  6. Andrew P. Merrill Research Fellowship award through Mclean Hospital
  7. Kaplen Fellowship on Depression award through Harvard Medical School
  8. NIMH [K23MH097786, R01MH68376, 1R01MH095809]
  9. Mclean Hospital
  10. NIDA [K24DA019855]

向作者/读者索取更多资源

The goals of the present study were to examine: (a) putative dysfunctions in reward responsiveness in a sample of adolescents (n = 40) with co-occurring depressive and substance use disorders; (b) possible links between reward responsiveness and symptoms of depression, anhedonia, anxiety, and motivation for change in relation to alcohol and drug use; and (c) potential gender differences in findings. Before and after a 2-week residential treatment, adolescents completed self-report assessments of depression, anhedonia, anxiety symptoms, and motivation for change in relation to substance use. In addition, participants completed a computer-based Probabilistic Reward Task (PRT) to examine reward responsiveness (i.e., participants' ability to modulate behavior as a function of reinforcement history). Results indicated that depression and anhedonia symptoms decreased, and motivation for change in relation to drug use increased. Improved reward responsiveness over the course of residential treatment emerged in female, but not male, participants.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

3.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据